In the News
November 29, 2017
The Pink Sheet | Combination Therapies: Incentives Needed To Encourage Labeling Across Products
Marc Scheineson comments on the need for the U.S. Food and Drug Administration to streamline the process for ensuring that drugs used together as part of a treatment regimen are similarly labeled for combination therapy.
Media Contact